Fletcher W H, Byus C V
J Cell Biol. 1982 Jun;93(3):719-26. doi: 10.1083/jcb.93.3.719.
A specific and sensitive procedure has been developed that reliably localizes intracellular sites of free catalytic unit (C) dissociated from cAMP-dependent protein kinase. The method is based on a FITC conjugate (F:PKI) of affinity column-purified heat-stable protein inhibitor (PKI) of free C. The fidelity of this cytochemical probe was determined using cultures of Reuber H-35 hepatoma cells that had been stimulated for 2 h with 0.1 mM DBcAMP, or with diluent, then fixed with anhydrous acetone at -30 degrees C. In these preparations the F:PKI probe complexed with free C in cytoplasm, nucleolus, and, to a minor extent, in nucleoplasm. Binding of the F:PKI molecule to free C was competitively diminished by arginine analogues, guanidinium HCI and polyarginine, each used over a 2-log dose range. When the inhibitor's arginine residues were blocked by reaction with cyclohexanedione it no longer inhibited phosphotransferase activity of free C, and when fluorescinated it failed to localize C in stimulated cells. Similarly, when F:PKI was preabsorbed with excess pure C it no longer functioned as a cytochemical stain. Affinity column-purified antibody to free C also reduced significantly the ability of F:PKI to complex with C in cell cultures stimulated with 0.1 mM DBcAMP. 1 microgram of antibody reduced by approximately 10% the binding of F:PKI to all cell compartments while 5 microgram of antibody diminished binding by greater than 50%. Together, these results indicate that the F:PKI binds specifically, perhaps exclusively, to the catalytic units of cAMP-dependent protein kinase. The cytochemical procedure, unlike its biochemical counterparts, is able to locate the dissociation of cAMP-dependent protein kinase in individual cells of functionally or histologically complex cultures. Also, it reveals variations in the time- and dose-dependent activation of the kinase amongst clonal cells stimulated with cyclic nucleotide analogues or hormones.
已开发出一种特异且灵敏的方法,可可靠地定位从环磷酸腺苷(cAMP)依赖性蛋白激酶解离出的游离催化亚基(C)在细胞内的位置。该方法基于亲和柱纯化的游离C的热稳定蛋白抑制剂(PKI)的异硫氰酸荧光素(FITC)偶联物(F:PKI)。使用鲁伯H - 35肝癌细胞培养物来确定这种细胞化学探针的保真度,这些细胞先用0.1 mM二丁酰环磷腺苷(DBcAMP)或稀释剂刺激2小时,然后在-30℃用无水丙酮固定。在这些制剂中,F:PKI探针与细胞质、核仁以及少量核质中的游离C结合。F:PKI分子与游离C的结合被精氨酸类似物、盐酸胍和聚精氨酸竞争性减弱,每种物质均在2个对数剂量范围内使用。当抑制剂的精氨酸残基通过与环己二酮反应被封闭时,它不再抑制游离C的磷酸转移酶活性,并且荧光素化后,它无法在受刺激细胞中定位C。同样,当F:PKI用过量的纯C预先吸附时,它不再作为细胞化学染色剂起作用。亲和柱纯化的针对游离C的抗体也显著降低了F:PKI在0.1 mM DBcAMP刺激的细胞培养物中与C结合的能力。1微克抗体使F:PKI与所有细胞区室的结合减少约10%,而5微克抗体使结合减少超过50%。总之,这些结果表明F:PKI特异性地,也许是唯一地,与cAMP依赖性蛋白激酶的催化亚基结合。这种细胞化学方法与其生化对应方法不同,能够在功能或组织学复杂培养物的单个细胞中定位cAMP依赖性蛋白激酶的解离。此外,它揭示了在用环核苷酸类似物或激素刺激的克隆细胞中,激酶的时间和剂量依赖性激活的变化。